Femasys (FEMY) Cash & Equivalents (2020 - 2026)

Femasys' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $5.4 million for Q1 2026.

• Quarterly Cash & Equivalents rose 40.99% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 40.99% YoY) and the FY2025 annual result came in at $9.3 million, up 168.45% from the prior year.
• Cash & Equivalents was $5.4 million for Q1 2026 at Femasys, down from $9.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $21.8 million in Q1 2022 and bottomed at $3.2 million in Q2 2025.
• A 5-year average of $11.2 million and a median of $10.2 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents plunged 84.11% — and 2025, when it surged 168.45%.
• Femasys' Cash & Equivalents stood at $13.0 million in 2022, then surged by 67.54% to $21.7 million in 2023, then plunged by 84.11% to $3.5 million in 2024, then jumped by 168.45% to $9.3 million in 2025, then plunged by 41.88% to $5.4 million in 2026.
• Business Quant data shows FEMY's Cash & Equivalents at $5.4 million in Q1 2026, $9.3 million in Q4 2025, and $4.6 million in Q3 2025.